Akadolyun Soft Capsule 0.5 Micrograms (Alfacalcidol)

Adult dosage

Chronic renal failure and osteoporosis: Administer 0.5–1 µg orally once daily as Alfacalcidol. Hypoparathyroidism and other conditions related to vitamin D metabolism abnormalities: Administer 1–4 µg orally once daily as this medication.

Children's dosage

Osteoporosis: Administer 0.01–0.03 µg per kg body weight orally once daily as Alfacalcidol. Other diseases: Administer 0.05–0.1 µg per kg body weight orally once daily as this medication.

This medication should not be taken by patients with high levels of calcium, phosphorus, or magnesium in the blood, or by patients with alkalosis. It should also be avoided if experiencing symptoms of vitamin D toxicity or if allergic to this drug. It is important not to take this medication concurrently with magnesium-containing preparations, vitamin D and its derivatives, calcium-containing preparations, or certain diuretics. During breastfeeding, it is advisable to avoid use if the safety is not established; if it must be taken, consider stopping breastfeeding. Women who are pregnant or may become pregnant should consult a physician about the potential effects on the fetus before taking it. Caution is needed for children, the elderly, those with a history of kidney stones, and patients taking certain medications, and they should consult an expert. If any abnormal symptoms occur while taking this medication, it should be discontinued immediately and medical advice should be sought. Adverse effects can occur in various areas including the digestive system, nervous system, circulatory system, kidneys, liver, skin, eyes, and musculoskeletal system, hence careful observation is required. Regularly check serum calcium levels to prevent overdose and manage calcium and phosphorus levels. Immediate emergency treatment and appropriate therapy are necessary for overdose, so visit a medical institution promptly if symptoms appear. This medication should be stored out of reach of children, protected from direct sunlight, and kept in a cool, dry place, sealed. Also, do not transfer the drug to another container, and strictly adhere to the prescribed dosage and administration to avoid misuse.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, high fever with severe rash, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or breathing difficulty, asthma attacks, respiratory abnormalities with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, significantly decreased urine output, severe generalized swelling

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• discomfort in the upper abdomen
• abdominal bloating
• indigestion
• thirst

This medication should be stored in a hermetically sealed container to prevent air exposure, ideally at a temperature between 1°C and 30°C at room temperature. Storing it this way helps maintain the medication's effectiveness and prevents degradation.

Appearance

Yellow to light yellow oval soft capsule containing a yellow transparent emulsion

Package unit

For domestic use - 90 capsules/bottle, For domestic use - 30 capsules/bottle